HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shimpei Iikuni Selected Research

multidrug resistance-associated protein 1

1/2021Increased [18F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shimpei Iikuni Research Topics

Disease

14Neoplasms (Cancer)
01/2022 - 01/2018
5Alzheimer Disease (Alzheimer's Disease)
05/2021 - 01/2013
4Parkinson Disease (Parkinson's Disease)
10/2022 - 12/2020
4Multiple System Atrophy
10/2022 - 12/2020
3Synucleinopathies
10/2022 - 12/2020
3Dementia (Dementias)
10/2022 - 01/2022
3Hypoxia (Hypoxemia)
01/2021 - 01/2018
2Multiple Sclerosis
01/2022 - 12/2020
2Insulinoma
01/2022 - 01/2022
2Type 2 Diabetes Mellitus (MODY)
11/2020 - 01/2020
2Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2016 - 01/2016
2Amyloid Plaque
10/2014 - 01/2013
2Amyloidosis
04/2014 - 01/2013
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022
1Demyelinating Diseases (Demyelinating Disease)
01/2022
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Hyperlipidemias (Hyperlipidemia)
06/2019
1Atherosclerosis
06/2019
1Cerebral Hemorrhage
01/2016
1Cognitive Dysfunction
01/2016

Drug/Important Bio-Agent (IBA)

7Carbonic Anhydrase IXIBA
01/2021 - 01/2018
7Amyloid (Amyloid Fibrils)IBA
11/2020 - 01/2013
4SynucleinsIBA
10/2022 - 12/2020
3SulfonamidesIBA
01/2021 - 01/2020
3imidazothiadiazoleIBA
01/2021 - 01/2020
2AcidsIBA
01/2022 - 12/2021
2Exenatide (Byetta)FDA Link
01/2022 - 01/2022
2Glucagon-Like Peptide-1 ReceptorIBA
01/2022 - 01/2022
2tau Proteins (tau Protein)IBA
05/2021 - 01/2019
2Therapeutic UsesIBA
01/2021 - 01/2018
2LipidsIBA
12/2020 - 06/2019
2Radioisotopes (Radionuclides)IBA
01/2020 - 01/2018
2benzofuranIBA
10/2014 - 01/2013
1OxadiazolesIBA
01/2022
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2022
1Human Serum AlbuminFDA LinkGeneric
12/2021
1AlbuminsIBA
12/2021
1NitroimidazolesIBA
03/2021
1fluoromisonidazoleIBA
01/2021
1Lapatinib (GW572016)FDA Link
01/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1verlukastIBA
01/2021
1multidrug resistance-associated protein 1IBA
01/2021
1AntigensIBA
01/2021
13-phenylcoumarinIBA
12/2020
1LigandsIBA
11/2020
1Islet Amyloid PolypeptideIBA
11/2020
1ZincIBA
01/2020
1EnzymesIBA
01/2020
14,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
06/2019
1Acetazolamide (Diamox)FDA LinkGeneric
01/2019

Therapy/Procedure

4Therapeutics
01/2020 - 01/2013
3Precision Medicine
06/2021 - 01/2018
2Radiotherapy
01/2019 - 01/2018
1Intravenous Administration
03/2021
1Aftercare (After-Treatment)
01/2021
1Castration
01/2021
1Drug Therapy (Chemotherapy)
01/2019